News
[March 2018 marked Centaur’s alliance with Kibow Biotech to market Renadyl India and eventually manufacture and market with technical inputs from Kibow Biotech. Check Centaur’s news on Renadyl.]
Centaur Pharma’s news announcement on celebrating Anti-Cold Day in India, which marked the 10th year of Common Cold Awareness Week Campaign. The campaign aimed to raise awareness about common cold with the intent to avoid self-medication and urged people to consult a Doctor.
[Natarajan Ranganathan, Founder and Managing Director-Research and Development, Kibow Biotech, Newtown Square, USA talks about the collaboration with Centaur Pharma on marketing Renadyl in India. He also talks about the need for reduction in the expenses for dialysis in India and how Renadyl can be an apt solution.]
[Mr. S.D Sawant, Founder and M.D, talks about Centaur Pharma and its development in the last 35 years in an interview with Shahid Akhter, Editor, ET Healthworld. Centaur being the largest producers of psychotropic API with its manufacturing facility in Ambernath, has collaborated with Kibow Biotech in the marketing and manufacturing of Renadyl, a supplement for CKD patients in India – a significant leap at Centaur pharma for managing CKD in India.]
[Indian Express reports on how it’s not about how big the Pharma firm is, but how popular they can make their brands and reports on Sinarest.]